Clinical trial
Low Dose IL-2 for the Treatment of Crohn's Disease
NCT04263831 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low Dose IL-2 for the Treatment of Crohn's Disease
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- March 11, 2021
- Completion date
- December 30, 2027
- Enrollment
- 30 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.